Location History:
- Sennan-gun, JP (1997)
- Izumisano, JP (2000 - 2004)
- Osaka, JP (2007)
Company Filing History:
Years Active: 1997-2007
Title: Toshiaki Aoyama: Innovator in Lipid Reduction Technologies
Introduction
Toshiaki Aoyama is a notable inventor based in Izumisano, Japan. He has made significant contributions to the field of lipid reduction, particularly through his innovative compositions aimed at diminishing neutral fat and lipids in blood. With a total of 4 patents to his name, Aoyama's work is recognized for its potential health benefits.
Latest Patents
Aoyama's latest patents include a composition for diminishing neutral fat in blood. This invention provides a neutral fat reducing composition that safely and efficiently reduces blood neutral fat. The active ingredient is a soybean protein containing 50% or more of a 7S globulin fractionated from soybean protein, with 0.2% or less of phytate based on the proteins. The effectiveness of this composition is enhanced by removing oil-body-associated proteins and reducing chloroform methanol-extractable oil fractions.
Another significant patent is a fats and oils composition for reducing lipids in blood. This invention comprises a triglyceride in which specified fatty acids are artificially combined at different portions of the triglyceride molecule. The composition is particularly useful for foods and includes triglycerides containing a R R R triglyceride as an effective component.
Career Highlights
Throughout his career, Toshiaki Aoyama has worked with prominent companies such as Fuji Oil Company Limited and Nisshin Oillio, Ltd. His experience in these organizations has contributed to his expertise in developing innovative solutions for lipid reduction.
Collaborations
Aoyama has collaborated with notable coworkers, including Hirokazu Maeda and Mitsutaka Kohno. These partnerships have likely facilitated the advancement of his research and inventions.
Conclusion
Toshiaki Aoyama's contributions to lipid reduction technologies through his patents demonstrate his commitment to improving health outcomes. His innovative approaches continue to influence the field and offer promising solutions for managing blood lipid levels.